We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


IO Informatics and Sage-N Research Announce Partnership

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "IO Informatics and Sage-N Research Announce Partnership"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

IO Informatics announces a strategic partnership with Sage-N Research, Inc. that includes the integration of Sage-N's SORCERER™ Enterprise with the IO Informatics' Sentient software suite. The combination of these technologies creates a Semantic application framework that has been used to quickly develop a highly specialized, large-scale application that leverages mass-spectrometry based Proteomics with unmatched content enrichment, interoperability, and flexibility only possible with semantic data integration.

"One application of this novel approach is to identify peptides from different microorganism with common mechanism of actions, and to categorize them as potential biomarkers, and it also has the capability to detect microbial threats prior to onset of disease symptoms," said Ali Pervez, Vice President of Marketing at Sage-N Research.

This new alliance was announced at the Human Proteome Organization (HUPO) 8th Annual Conference: The Future of Proteomics in San Francisco, CA. Using customer data and the newly combined technologies, Dr. Erich A. Gombocz, CSO of IO Informatics, highlighted the workflow in a talk entitled, "A novel approach to recognize peptide functions in microorganisms: Establishing systems biology-based relationship networks to better understand disease causes and prevention."

"Future applications of this technology will enable automated screening for biological threats, to characterize origin and type of disease and to develop preventive measures (drugs or vaccines) effective for several classes of microorganism," said Robert Stanley, President of IO Informatics.